Resmetirom and GLP-1 agonists for MASH: complementary rather than exclusive
Resmetirom: acts on the MASH and fibrosis regression by intrahepatic path Resmetirom is an orally administered, liver-targeted thyroid hormone receptor-β (THRβ) selective agonist. The FDA’s…
